Delivery Order SPE2DR25D2211-SPE2DR26FM8C8
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector units, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Benlysta 200 mg/ml auto-injectors. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a non-competitive set-aside award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency has awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. The contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, represents a firm fixed-price delivery under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $19,491.96 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside contract with a completion date of January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this delivery...
- The Defense Logistics Agency awarded a $18,496.02 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on August 14, 2025, with completion targeted for September 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, to be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $3,248.66 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Benlysta 200 mg/mL auto-injector. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. This firm fixed-price delivery order, valued at $6,165.36, is scheduled for completion by November 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, demonstrating the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D2211Indefinite Delivery Contract
- SPE2DR25D2211-SPE2DR26FM8C8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector supply. This non-competitive delivery order, issued on December 26, 2025, is expected to be completed by January 20, 2026, and represents a firm fixed-price transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract covers critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and related supplies for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/25/25 |